Quarterly Activity Chart
Adds vs. Reduces by Quarter
PaperPanda Equity Terminal
CRNX —
CRINETICS PHARMACEUTICALS IN
CUSIP: 22663K107 · Held by 1 superinvestor · Combined value: $13,239,751
Latest News
Loading financials…
| # | Investor | % of Portfolio | Value ($) | Shares | Recent Activity | Share Change |
|---|---|---|---|---|---|---|
| 1 | Ken Griffin | 0.0% | $13,239,751 | 284,420 | REDUCE | -747,087 |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Ken Griffin | REDUCE | -747,087 | -72.4% |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Ken Griffin | ADD | +323,472 | +45.7% |
Who Owns CRNX? Superinvestor Holdings
CRINETICS PHARMACEUTICALS IN is held by 1 tracked superinvestor, with a combined position value of $13 million . The largest positions are held by Ken Griffin (0.0% of portfolio).
In the most recent quarter1 reduced or exited.